Biocryst Pharmaceuticals (BCRX) Net Margin Growth (1y) (2011 - 2026)
Biocryst Pharmaceuticals (BCRX) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | 3,281.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,281.00 |
| Mar 31, 2026 | -46,150.00 |
| Dec 31, 2025 | 3.47 Mn |
| Sep 30, 2025 | 2,008.00 |
| Jun 30, 2025 | 1,471.00 |
| Mar 31, 2025 | 3,816.00 |
| Dec 31, 2024 | 4,572.00 |
| Sep 30, 2024 | 2,969.00 |
| Jun 30, 2024 | 7,972.00 |
| Mar 31, 2024 | 3,940.00 |
| Dec 31, 2023 | 2,385.00 |
| Sep 30, 2023 | 1,440.00 |
| Jun 30, 2023 | -150.00 |
| Mar 31, 2023 | 7,108.00 |
| Dec 31, 2022 | -5,224.00 |
| Sep 30, 2022 | 8,736.00 |
| Jun 30, 2022 | -335.00 |
| Mar 31, 2022 | 18,867.00 |
| Dec 31, 2021 | 162,918.00 |
| Sep 30, 2021 | 61,210.00 |